Cost-effectiveness of transient elastography for liver fibrosis screening in Thai patients with diabetes mellitus

Figure 3 Probabilistic sensitivity analysis. A: Cost-effectiveness plane plotting incremental costs (vertical axis) against incremental quality-adjusted life-years (QALYs) (horizontal axis) for each strategy vs no screening. Points below the dashed purple line (Thai willingness-to-pay threshold) are deemed cost-effective; B: Cost-effectiveness acceptability curves illustrating, across a continuum of willingness-to-pay thresholds, the probability that each strategy is cost-effective; the current Thai threshold is marked by the dashed purple line. DM: Diabetes mellitus; FIB-4: Fibrosis-4 index; SAFE: Steatosis-associated fibrosis estimator score; TE: Transient elastography; THB: Thai baht.